4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double stranded linear DNA for viral and non-viral vector applications; opDNA, a…more
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double stranded linear DNA for viral and non-viral vector applications; opDNA, a…more
Analyst consensus: Buy
As of 21 Jul 2026, 2 analysts rate 4basebio PLC a Buy, with 100% buy ratings and a mean price target of 1,600p (range 1,400p–1,800p), +205% vs the current price.